| Year |
Citation |
Score |
| 2020 |
Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, et al. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. Jama Dermatology. PMID 32725204 DOI: 10.1001/Jamadermatol.2020.1729 |
0.348 |
|
| 2019 |
McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M. Editor's Note: Inhibition of Platelet-derived Growth Factor-mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 3196. PMID 31092620 DOI: 10.1158/1078-0432.Ccr-19-1101 |
0.463 |
|
| 2018 |
Shahzad MMK, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, et al. Stress effects on FosB and interleukin-8 ()-driven ovarian cancer growth and metastasis. The Journal of Biological Chemistry. 293: 10041. PMID 29959278 DOI: 10.1074/Jbc.Aac118.004299 |
0.344 |
|
| 2018 |
Nemlich Y, Baruch EN, Besser MJ, Shoshan E, Bar-Eli M, Anafi L, Barshack I, Schachter J, Ortenberg R, Markel G. ADAR1-mediated regulation of melanoma invasion. Nature Communications. 9: 2154. PMID 29855470 DOI: 10.1038/S41467-018-04600-2 |
0.473 |
|
| 2018 |
Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, ... ... Bar-Eli M, et al. ATP11B mediates platinum resistance in ovarian cancer. The Journal of Clinical Investigation. PMID 29809169 DOI: 10.1172/Jci122301 |
0.395 |
|
| 2018 |
Velazquez-Torres G, Shoshan E, Ivan C, Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C, Xie V, Brooks D, Jones SJM, Robertson AG, Calin G, Lopez-Berenstein G, Sood A, ... Bar-Eli M, et al. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nature Communications. 9: 461. PMID 29386624 DOI: 10.1038/S41467-018-02851-7 |
0.365 |
|
| 2017 |
Sood AK, Dalton HJ, Pradeep S, McGuire M, Hailemichael Y, Ma S, Lyons Y, Armaiz-Pena GN, Previs RA, Hansen JM, Rupaimoole R, Gonzalez-Villasana V, Cho MS, Wu S, Mangala LS, ... ... Bar-Eli M, et al. Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28855350 DOI: 10.1158/1078-0432.Ccr-17-0647 |
0.303 |
|
| 2017 |
Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, ... ... Bar-Eli M, et al. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biology. 18: 98. PMID 28535802 DOI: 10.1186/S13059-017-1224-0 |
0.326 |
|
| 2017 |
Mobley A, Zhang S, Bondaruk J, Wang Y, Majewski T, Caraway NP, Huang L, Shoshan E, Velazquez-Torres G, Nitti G, Lee S, Lee JG, Fuentes-Mattei E, Willis D, Zhang L, ... ... Bar-Eli M, et al. Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Scientific Reports. 7: 40714. PMID 28102366 DOI: 10.1038/Srep40714 |
0.456 |
|
| 2016 |
Jinesh GG, Molina JR, Huang L, Laing NM, Mills GB, Bar-Eli M, Kamat AM. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. Cell Death Discovery. 2: 16003. PMID 27551498 DOI: 10.1038/Cddiscovery.2016.3 |
0.316 |
|
| 2016 |
Rosero RA, Villares GJ, Bar-Eli M. Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection. Frontiers in Genetics. 7: 112. PMID 27379162 DOI: 10.3389/Fgene.2016.00112 |
0.755 |
|
| 2016 |
Wu SY, Rupaimoole R, Shen F, Pradeep S, Pecot CV, Ivan C, Nagaraja AS, Gharpure KM, Pham E, Hatakeyama H, McGuire MH, Haemmerle M, Vidal-Anaya V, Olsen C, Rodriguez-Aguayo C, ... ... Bar-Eli M, et al. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. Nature Communications. 7: 11169. PMID 27041221 DOI: 10.1038/Ncomms11169 |
0.306 |
|
| 2016 |
Shoshan E, Braeuer RR, Kamiya T, Mobley AK, Huang L, Vasquez ME, Velazquez-Torres G, Chakravarti N, Ivan C, Prieto VG, Villares GJ, Bar-Eli M. NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis. Cancer Research. PMID 27013197 DOI: 10.1158/0008-5472.Can-15-2511 |
0.799 |
|
| 2016 |
Rupaimoole R, Ivan C, Yang D, Gharpure KM, Wu SY, Pecot CV, Previs RA, Nagaraja AS, Armaiz-Pena GN, McGuire M, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Huang L, Bar-Eli M, et al. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene. PMID 26725326 DOI: 10.1038/Onc.2015.492 |
0.366 |
|
| 2015 |
Flashner-Abramson E, Klein S, Mullin G, Shoshan E, Song R, Shir A, Langut Y, Bar-Eli M, Reuveni H, Levitzki A. Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling. Oncogene. PMID 26119932 DOI: 10.1038/Onc.2015.229 |
0.376 |
|
| 2015 |
Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, Velazquez-Torres G, Nip KM, Zhu K, Brooks D, Jones SJ, ... ... Bar-Eli M, et al. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nature Cell Biology. 17: 311-21. PMID 25686251 DOI: 10.1038/Ncb3110 |
0.377 |
|
| 2015 |
Izraely S, Sagi-Assif O, Klein A, Meshel T, Ben-Menachem S, Zaritsky A, Ehrlich M, Prieto VG, Bar-Eli M, Pirker C, Berger W, Nahmias C, Couraud PO, Hoon DS, Witz IP. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. International Journal of Cancer. Journal International Du Cancer. 136: 1296-307. PMID 25046141 DOI: 10.1002/Ijc.29090 |
0.422 |
|
| 2014 |
Dalton HJ, Armaiz-Pena GN, Gonzalez-Villasana V, Lopez-Berestein G, Bar-Eli M, Sood AK. Monocyte subpopulations in angiogenesis. Cancer Research. 74: 1287-93. PMID 24556724 DOI: 10.1158/0008-5472.Can-13-2825 |
0.39 |
|
| 2014 |
Braeuer RR, Watson IR, Wu CJ, Mobley AK, Kamiya T, Shoshan E, Bar-Eli M. Why is melanoma so metastatic? Pigment Cell & Melanoma Research. 27: 19-36. PMID 24106873 DOI: 10.1111/Pcmr.12172 |
0.47 |
|
| 2014 |
Czerniak BA, Lee S, Bondaruk J, Lee S, Majewski T, Zhang S, Shen L, Liu Y, Guo C, Dinney C, Grossman HB, Zhang W, Bar-Eli M, Baggerly K, Behringer R, et al. Abstract 5256: Mechanism of field cancerization Cancer Research. 74: 5256-5256. DOI: 10.1158/1538-7445.Am2014-5256 |
0.375 |
|
| 2014 |
Shoshan E, Mobley A, Braeuer R, Kamiya T, Huang L, Vasquez M, Jeong LH, kim SJ, Calin G, Sood A, Markel G, Fidler I, Bar-Eli M. Abstract 4969: Hypo adenosine-to-inosine editing of microRNA-455 promotes melanoma metastasis Cancer Research. 74: 4969-4969. DOI: 10.1158/1538-7445.Am2014-4969 |
0.415 |
|
| 2013 |
Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, ... ... Bar-Eli M, et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. The Journal of Clinical Investigation. 123: 2703-18. PMID 23728176 DOI: 10.1172/Jci62980 |
0.352 |
|
| 2013 |
Reuveni H, Flashner-Abramson E, Steiner L, Makedonski K, Song R, Shir A, Herlyn M, Bar-Eli M, Levitzki A. Therapeutic destruction of insulin receptor substrates for cancer treatment. Cancer Research. 73: 4383-94. PMID 23651636 DOI: 10.1158/0008-5472.Can-12-3385 |
0.414 |
|
| 2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, ... ... Bar-Eli M, et al. Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nature Communications. 4: 1403. PMID 23360994 DOI: 10.1038/Ncomms2413 |
0.739 |
|
| 2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, ... ... Bar-Eli M, et al. Erratum: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis Nature Communications. 4. DOI: 10.1038/Ncomms2903 |
0.703 |
|
| 2012 |
Braeuer RR, Zigler M, Kamiya T, Dobroff AS, Huang L, Choi W, McConkey DJ, Shoshan E, Mobley AK, Song R, Raz A, Bar-Eli M. Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin Cancer Research. 72: 5757-5766. PMID 22986745 DOI: 10.1158/0008-5472.Can-12-2424 |
0.567 |
|
| 2012 |
Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Retraction Note: Targeting EGFR in bladder cancer World Journal of Urology. 30: 723-723. PMID 22972001 DOI: 10.1007/S00345-012-0940-Z |
0.703 |
|
| 2012 |
Mobley AK, Braeuer RR, Kamiya T, Shoshan E, Bar-Eli M. Driving transcriptional regulators in melanoma metastasis. Cancer Metastasis Reviews. 31: 621-32. PMID 22684365 DOI: 10.1007/S10555-012-9358-8 |
0.422 |
|
| 2012 |
Braeuer RR, Shoshan E, Kamiya T, Bar-Eli M. The sweet and bitter sides of galectins in melanoma progression. Pigment Cell & Melanoma Research. 25: 592-601. PMID 22672152 DOI: 10.1111/J.1755-148X.2012.01026.X |
0.503 |
|
| 2012 |
Bar-Eli M. Back to the embryonic stage: Nodal as a biomarker for breast cancer progression. Breast Cancer Research : Bcr. 14: 105. PMID 22643182 DOI: 10.1186/Bcr3177 |
0.384 |
|
| 2012 |
Mu H, Calderone TL, Davies MA, Prieto VG, Wang H, Mills GB, Bar-Eli M, Gershenwald JE. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. The American Journal of Pathology. 180: 2170-81. PMID 22465753 DOI: 10.1016/J.Ajpath.2012.03.003 |
0.411 |
|
| 2012 |
Braeuer RR, Zigler M, Kamiya T, Dobroff AS, Huang L, Bar-Eli M. Abstract LB-301: Galectin-3 contributes to melanoma metastasis by regulating Autotaxin through NFAT1 Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-301 |
0.573 |
|
| 2011 |
Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6. PMID 22009534 DOI: 10.1158/0008-5472.Can-11-1432 |
0.797 |
|
| 2011 |
Patel SP, Kim KB, Papadopoulos NE, Hwu WJ, Hwu P, Prieto VG, Bar-Eli M, Zigler M, Dobroff A, Bronstein Y, Bassett RL, Vardeleon AG, Bedikian AY. A phase II study of gefitinib in patients with metastatic melanoma. Melanoma Research. 21: 357-63. PMID 21738104 DOI: 10.1097/Cmr.0B013E3283471073 |
0.386 |
|
| 2011 |
Zigler M, Villares GJ, Dobroff AS, Wang H, Huang L, Braeuer RR, Kamiya T, Melnikova VO, Song R, Friedman R, Alani RM, Bar-Eli M. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Research. 71: 3494-504. PMID 21467165 DOI: 10.1158/0008-5472.Can-10-3555 |
0.79 |
|
| 2011 |
Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target. Oncotarget. 2: 8-17. PMID 21378407 DOI: 10.18632/Oncotarget.211 |
0.79 |
|
| 2011 |
Villares GJ, Zigler M, Dobroff AS, Wang H, Song R, Melnikova VO, Huang L, Braeuer RR, Bar-Eli M. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 626-31. PMID 21187389 DOI: 10.1073/Pnas.1006886108 |
0.803 |
|
| 2011 |
Black PC, Brown GA, Dinney CP, Kassouf W, Inamoto T, Arora A, Gallagher D, Munsell MF, Bar-Eli M, McConkey DJ, Adam L. Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer. The Journal of Urology. 185: 693-700. PMID 21168861 DOI: 10.1016/J.Juro.2010.09.082 |
0.383 |
|
| 2011 |
Braeuer RR, Zigler M, Villares GJ, Dobroff AS, Bar-Eli M. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Seminars in Cancer Biology. 21: 83-8. PMID 21147226 DOI: 10.1016/J.Semcancer.2010.12.007 |
0.798 |
|
| 2011 |
Pena GNA, Stone RL, Nick AM, Villares GJ, Cruz A, Vivas-Mejias P, Wu Z, English RD, Soman KV, Deavers MT, Zien A, Soldatos T, Jackson DB, Wiktorowicz JE, Torres-Lugo M, ... ... Bar-Eli M, et al. Abstract 937: Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth Cancer Research. 71: 937-937. DOI: 10.1158/1538-7445.Am2011-937 |
0.758 |
|
| 2010 |
Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, et al. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. The Journal of Biological Chemistry. 285: 35462-70. PMID 20826776 DOI: 10.1074/Jbc.M110.109579 |
0.4 |
|
| 2010 |
Lin Q, Balasubramanian K, Fan D, Kim SJ, Guo L, Wang H, Bar-Eli M, Aldape KD, Fidler IJ. Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia (New York, N.Y.). 12: 748-54. PMID 20824051 DOI: 10.1593/Neo.10602 |
0.382 |
|
| 2010 |
Melnikova VO, Dobroff AS, Zigler M, Villares GJ, Braeuer RR, Wang H, Huang L, Bar-Eli M. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma. Plos One. 5: e12452. PMID 20805990 DOI: 10.1371/Journal.Pone.0012452 |
0.735 |
|
| 2010 |
Merritt WM, Bar-Eli M, Sood AK. The dicey role of Dicer: implications for RNAi therapy. Cancer Research. 70: 2571-4. PMID 20179193 DOI: 10.1158/0008-5472.Can-09-2536 |
0.361 |
|
| 2010 |
Lee S, Lee S, Bondaruk J, Wang H, Zhang S, Bar-Eli M, Black P, Dinney C, Grossman HB, Knowles M, Baggerley K, Czerniak B. Abstract 3065: Loss of ARL11 function promotes growth ofin situneoplasia by activating the ras pathway Cancer Research. 70: 3065-3065. DOI: 10.1158/1538-7445.Am10-3065 |
0.402 |
|
| 2010 |
Zigler M, Villares GJ, Dobroff AS, Braeuer RR, Wang H, Huang L, Alani RM, Bar-Eli M. Abstract 2369: The adhesion molecule MCAM/MUC18 regulates the expression of Id-1 and contributes to melanoma invasion and metastasis Cancer Research. 70: 2369-2369. DOI: 10.1158/1538-7445.Am10-2369 |
0.796 |
|
| 2010 |
Dobroff AS, Melnikova VO, Villares GJ, Zigler M, Braeuer RR, Wang H, Huang L, Bar-Eli M. Abstract 2353: CREB regulates AP-2α transcription to determine the malignant phenotype of melanoma Cancer Research. 70: 2353-2353. DOI: 10.1158/1538-7445.Am10-2353 |
0.773 |
|
| 2009 |
Steeg PS, Anderson RL, Bar-Eli M, Chambers AF, Eccles SA, Hunter K, Itoh K, Kang Y, Matrisian LM, Sleeman JP, Theodorescu D, Thompson EW, Welch DR. An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4529. PMID 25278743 DOI: 10.1158/1078-0432.Ccr-09-1363 |
0.369 |
|
| 2009 |
Yang J, Price MA, Li GY, Bar-Eli M, Salgia R, Jagedeeswaran R, Carlson JH, Ferrone S, Turley EA, McCarthy JB. Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. Cancer Research. 69: 7538-47. PMID 19738072 DOI: 10.1158/0008-5472.Can-08-4626 |
0.513 |
|
| 2009 |
Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. The Journal of Biological Chemistry. 284: 28845-55. PMID 19703903 DOI: 10.1074/Jbc.M109.042150 |
0.8 |
|
| 2009 |
Villares GJ, Dobroff AS, Wang H, Zigler M, Melnikova VO, Huang L, Bar-Eli M. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Research. 69: 6730-7. PMID 19679555 DOI: 10.1158/0008-5472.Can-09-0300 |
0.799 |
|
| 2009 |
Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5060-72. PMID 19671845 DOI: 10.1158/1078-0432.Ccr-08-2245 |
0.414 |
|
| 2009 |
Dobroff AS, Wang H, Melnikova VO, Villares GJ, Zigler M, Huang L, Bar-Eli M. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. The Journal of Biological Chemistry. 284: 26194-206. PMID 19632997 DOI: 10.1074/Jbc.M109.019836 |
0.808 |
|
| 2009 |
Melnikova VO, Bar-Eli M. Inflammation and melanoma metastasis. Pigment Cell & Melanoma Research. 22: 257-67. PMID 19368690 DOI: 10.1111/J.1755-148X.2009.00570.X |
0.432 |
|
| 2009 |
Armaiz-Pena G, Villares G, Han L, Lin Y, Sanguino A, Deavers M, Gallick G, Bar-Eli M, Lopez-Berestein G, Cole S, Lutgendorf S, Sood A. 5. Molecular mechanisms of Src activation in chronic stress-induced cancer growth Brain, Behavior, and Immunity. 23: S26. DOI: 10.1016/J.Bbi.2009.06.010 |
0.715 |
|
| 2008 |
Melnikova VO, Villares GJ, Bar-Eli M. Emerging roles of PAR-1 and PAFR in melanoma metastasis. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 1: 103-11. PMID 19308689 DOI: 10.1007/S12307-008-0002-7 |
0.79 |
|
| 2008 |
Mourad-Zeidan AA, Melnikova VO, Wang H, Raz A, Bar-Eli M. Expression profiling of galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry American Journal of Pathology. 173: 1839-1852. PMID 18988806 DOI: 10.2353/Ajpath.2008.080380 |
0.537 |
|
| 2008 |
Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R, Leslie MC, Vivas-Mejia PE, Lopez-Berestein G, Sood AK, Bar-Eli M. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Research. 68: 9078-86. PMID 18974154 DOI: 10.1158/0008-5472.Can-08-2397 |
0.787 |
|
| 2008 |
Staquicini FI, Tandle A, Libutti SK, Sun J, Zigler M, Bar-Eli M, Aliperti F, Pérez EC, Gershenwald JE, Mariano M, Pasqualini R, Arap W, Lopes JD. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Research. 68: 8419-28. PMID 18922915 DOI: 10.1158/0008-5472.Can-08-1242 |
0.454 |
|
| 2008 |
Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, ... ... Bar-Eli M, et al. Phase II trial of imatinib mesylate in patients with metastatic melanoma. British Journal of Cancer. 99: 734-40. PMID 18728664 DOI: 10.1038/Sj.Bjc.6604482 |
0.411 |
|
| 2008 |
Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. American Journal of Clinical Dermatology. 9: 307-11. PMID 18717605 DOI: 10.2165/00128071-200809050-00004 |
0.761 |
|
| 2008 |
Melnikova VO, Bar-Eli M. Searching for the Achilles' heel of melanoma cells: new treatment modalities. Pigment Cell & Melanoma Research. 21: 505-6. PMID 18713130 DOI: 10.1111/J.1755-148X.2008.00493.X |
0.314 |
|
| 2008 |
Melnikova VO, Bar-Eli M. Transcriptional control of the melanoma malignant phenotype. Cancer Biology & Therapy. 7: 997-1003. PMID 18698165 DOI: 10.4161/Cbt.7.7.6535 |
0.517 |
|
| 2008 |
Kassouf W, Brown GA, Black PC, Fisher MB, Inamoto T, Luongo T, Gallagher D, Bar-Eli M, McConkey DJ, Adam L, Dinney CP. Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer? The Journal of Urology. 180: 1146-53. PMID 18639280 DOI: 10.1016/J.Juro.2008.05.001 |
0.383 |
|
| 2008 |
Kuwai T, Nakamura T, Sasaki T, Kim SJ, Fan D, Villares GJ, Zigler M, Wang H, Bar-Eli M, Kerbel RS, Fidler IJ. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors. Neoplasia (New York, N.Y.). 10: 489-500. PMID 18472966 DOI: 10.1593/Neo.08200 |
0.777 |
|
| 2008 |
Majewski T, Lee S, Jeong J, Yoon DS, Kram A, Kim MS, Tuziak T, Bondaruk J, Lee S, Park WS, Tang KS, Chung W, Shen L, Ahmed SS, Johnston DA, ... ... Bar-Eli M, et al. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 694-721. PMID 18458673 DOI: 10.1038/Labinvest.2008.27 |
0.306 |
|
| 2008 |
Lu C, Shahzad MM, Wang H, Landen CN, Kim SW, Allen J, Nick AM, Jennings N, Kinch MS, Bar-Eli M, Sood AK. EphA2 overexpression promotes ovarian cancer growth. Cancer Biology & Therapy. 7: 1098-103. PMID 18443431 DOI: 10.4161/Cbt.7.7.6168 |
0.491 |
|
| 2008 |
Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP. Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1478-86. PMID 18316572 DOI: 10.1158/1078-0432.Ccr-07-1593 |
0.398 |
|
| 2008 |
Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, Han LY, Landen CN, Jennings N, De Geest K, Langley RR, Villares G, Sanguino A, Lutgendorf SK, Lopez-Berestein G, Bar-Eli MM, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. Journal of the National Cancer Institute. 100: 359-72. PMID 18314475 DOI: 10.1093/Jnci/Djn024 |
0.712 |
|
| 2008 |
Ban K, Gao Y, Amin HM, Howard A, Miller C, Lin Q, Leng X, Munsell M, Bar-Eli M, Arlinghaus RB, Chandra J. BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. Blood. 111: 2904-8. PMID 18180382 DOI: 10.1182/Blood-2007-05-091769 |
0.435 |
|
| 2008 |
Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP. Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer. The Journal of Urology. 179: 353-8. PMID 18006009 DOI: 10.1016/J.Juro.2007.08.087 |
0.372 |
|
| 2007 |
Melnikova V, Bar-Eli M. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer Metastasis Reviews. 26: 359-71. PMID 17721743 DOI: 10.1007/S10555-007-9092-9 |
0.515 |
|
| 2007 |
Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH, Shen L, Bondaruk J, Ahmed SS, Samanta S, Spiess P, ... ... Bar-Eli M, et al. Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. Proceedings of the National Academy of Sciences of the United States of America. 104: 13732-7. PMID 17702869 DOI: 10.1073/Pnas.0701771104 |
0.364 |
|
| 2007 |
Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Targeting EGFR in bladder cancer. World Journal of Urology. 25: 573-9. PMID 17690890 DOI: 10.1007/S00345-007-0202-7 |
0.751 |
|
| 2007 |
Schwartz B, Shoseyov O, Melnikova VO, McCarty M, Leslie M, Roiz L, Smirnoff P, Hu GF, Lev D, Bar-Eli M. ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis. Cancer Research. 67: 5258-66. PMID 17545605 DOI: 10.1158/0008-5472.Can-07-0129 |
0.487 |
|
| 2007 |
Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell. 11: 447-60. PMID 17482134 DOI: 10.1016/J.Ccr.2007.03.009 |
0.39 |
|
| 2007 |
Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, Torrice C, Hao H, Penland S, Arbiser J, Scott G, Zhou T, Bar-Eli M, Bear JE, Der CJ, Kaufmann WK, et al. Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. Cancer Research. 67: 1502-12. PMID 17308088 DOI: 10.1158/0008-5472.Can-06-3311 |
0.436 |
|
| 2007 |
Shrader M, Pino MS, Lashinger L, Bar-Eli M, Adam L, Dinney CP, McConkey DJ. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression. Cancer Research. 67: 1430-5. PMID 17308080 DOI: 10.1158/0008-5472.Can-06-1224 |
0.435 |
|
| 2007 |
Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, Blehm K, Zhao YJ, McCarty M, Adam L, Bar-Eli M. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene. 26: 4049-58. PMID 17224907 DOI: 10.1038/Sj.Onc.1210193 |
0.729 |
|
| 2007 |
Leslie MC, Zhao YJ, Lachman LB, Hwu P, Bar-Eli M. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Therapy. 14: 316-323. PMID 17024104 DOI: 10.1038/Sj.Gt.3302864 |
0.445 |
|
| 2007 |
Mitchell DC, Stafford LJ, Li D, Bar-Eli M, Liu M. Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130 Oncogene. 26: 1739-1747. PMID 16964286 DOI: 10.1038/Sj.Onc.1209963 |
0.434 |
|
| 2007 |
Tellez CS, Davis DW, Prieto VG, Gershenwald JE, Johnson MM, McCarty MF, Bar-Eli M. Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. The Journal of Investigative Dermatology. 127: 387-93. PMID 16946713 DOI: 10.1038/Sj.Jid.5700539 |
0.763 |
|
| 2007 |
Leslie MC, Zhao YJ, Lachman LB, Hwu P, Wu GJ, Bar-Eli M. Erratum: Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis (Gene Therapy (2007) vol. 14 (316-323) 10.1038/sj.3302864) Gene Therapy. 14. DOI: 10.1038/Sj.Gt.3302926 |
0.329 |
|
| 2006 |
De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, et al. Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biology & Therapy. 5: 1588-99. PMID 17224636 DOI: 10.4161/Cbt.5.12.3660 |
0.35 |
|
| 2006 |
Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6709-15. PMID 17121890 DOI: 10.1158/1078-0432.Ccr-06-0758 |
0.461 |
|
| 2006 |
Melnikova VO, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Research / Sponsored by the European Society For Pigment Cell Research and the International Pigment Cell Society. 19: 395-405. PMID 16965268 DOI: 10.1111/J.1600-0749.2006.00331.X |
0.401 |
|
| 2006 |
Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4671-7. PMID 16899617 DOI: 10.1158/1078-0432.Ccr-06-0407 |
0.726 |
|
| 2006 |
Melnikova VO, Mourad-Zeidan AA, Lev DC, Bar-Eli M. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. The Journal of Biological Chemistry. 281: 2911-22. PMID 16306050 DOI: 10.1074/Jbc.M508683200 |
0.492 |
|
| 2006 |
Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M, Liu M. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. The Journal of Biological Chemistry. 281: 51-8. PMID 16260418 DOI: 10.1074/Jbc.M506245200 |
0.432 |
|
| 2005 |
Berger AJ, Davis DW, Tellez C, Prieto VG, Gershenwald JE, Johnson MM, Rimm DL, Bar-Eli M. Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction. Cancer Research. 65: 11185-92. PMID 16322269 DOI: 10.1158/0008-5472.Can-05-2300 |
0.74 |
|
| 2005 |
Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L. Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells. Cancer Research. 65: 10524-35. PMID 16288045 DOI: 10.1158/0008-5472.Can-05-1536 |
0.404 |
|
| 2005 |
Bales E, Mills L, Milam N, McGahren-Murray M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, Keyomarsi K, Medrano EE. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Research. 65: 692-7. PMID 15705861 |
0.31 |
|
| 2005 |
Leslie MC, Bar-Eli M. Regulation of gene expression in melanoma: new approaches for treatment. Journal of Cellular Biochemistry. 94: 25-38. PMID 15523674 DOI: 10.1002/Jcb.20296 |
0.53 |
|
| 2005 |
Emdad L, Sarkar D, Su ZZ, Boukerche H, Bar-Eli M, Fisher PB. Progression elevated gene-3 (PEG-3) induces pleiotropic effects on tumor progression: modulation of genomic stability and invasion. Journal of Cellular Physiology. 202: 135-46. PMID 15389539 DOI: 10.1002/Jcp.20097 |
0.448 |
|
| 2004 |
Chelouche-Lev D, Miller CP, Tellez C, Ruiz M, Bar-Eli M, Price JE. Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy. European Journal of Cancer (Oxford, England : 1990). 40: 2509-18. PMID 15519527 DOI: 10.1016/j.ejca.2004.05.024 |
0.715 |
|
| 2004 |
Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Research. 64: 7361-9. PMID 15492257 DOI: 10.1158/0008-5472.Can-04-0823 |
0.522 |
|
| 2004 |
Tellez C, Jean D, Bar-Eli M. Construction and expression of intracellular anti-ATF-1 single chain Fv fragment: a modality to inhibit melanoma tumor growth and metastasis. Methods (San Diego, Calif.). 34: 233-9. PMID 15312676 DOI: 10.1016/J.Ymeth.2004.03.016 |
0.762 |
|
| 2004 |
Lev DC, Onn A, Melinkova VO, Miller C, Stone V, Ruiz M, McGary EC, Ananthaswamy HN, Price JE, Bar-Eli M. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2092-100. PMID 15123733 DOI: 10.1200/Jco.2004.11.070 |
0.442 |
|
| 2004 |
Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ. The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. Molecular Cancer Therapeutics. 3: 279-90. PMID 15026548 |
0.379 |
|
| 2004 |
McGary EC, Onn A, Mills L, Heimberger A, Eton O, Thomas GW, Shtivelband M, Bar-Eli M. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo. The Journal of Investigative Dermatology. 122: 400-5. PMID 15009722 DOI: 10.1046/J.0022-202X.2004.22231.X |
0.501 |
|
| 2004 |
Zhang D, Bar-Eli M, Meloche S, Brodt P. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. The Journal of Biological Chemistry. 279: 19683-90. PMID 14993222 DOI: 10.1074/Jbc.M313145200 |
0.404 |
|
| 2004 |
Gershenwald JE, Bar-Eli M. Gene expression profiling of human cutaneous melanoma: are we there yet? Cancer Biology & Therapy. 3: 121-3. PMID 14764994 DOI: 10.4161/Cbt.3.1.728 |
0.362 |
|
| 2004 |
Ruiz M, Pettaway C, Song R, Stoeltzing O, Ellis L, Bar-Eli M. Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Research. 64: 631-8. PMID 14744778 DOI: 10.1158/0008-5472.Can-03-2751 |
0.399 |
|
| 2004 |
Rousselet N, Mills L, Jean D, Tellez C, Bar-Eli M, Frade R. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Research. 64: 146-51. PMID 14729618 DOI: 10.1158/0008-5472.Can-03-1717 |
0.681 |
|
| 2004 |
Nyormoi O, Mills L, Bar-Eli M. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death and Differentiation. 10: 558-69. PMID 12728254 DOI: 10.1038/Sj.Cdd.4401209 |
0.386 |
|
| 2003 |
McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 6560-6. PMID 14695161 |
0.36 |
|
| 2003 |
Tellez C, McCarty M, Ruiz M, Bar-Eli M. Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. The Journal of Biological Chemistry. 278: 46632-42. PMID 12975361 DOI: 10.1074/Jbc.M309159200 |
0.75 |
|
| 2003 |
Lev DC, Ruiz M, Mills L, McGary EC, Price JE, Bar-Eli M. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. Molecular Cancer Therapeutics. 2: 753-63. PMID 12939465 |
0.357 |
|
| 2003 |
Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ, Bar-Eli M. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 3167-75. PMID 12912969 |
0.729 |
|
| 2003 |
Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Tellez C, Williams S, Jung YD, Fan F, Takeda A, Akagi M, Bar-Eli M, Gallick GE, Ellis LM. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Research. 63: 3632-6. PMID 12839952 |
0.672 |
|
| 2003 |
Tellez C, Bar-Eli M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene. 22: 3130-7. PMID 12789289 DOI: 10.1038/Sj.Onc.1206453 |
0.768 |
|
| 2003 |
Nyormoi O, Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clinical & Experimental Metastasis. 20: 251-63. PMID 12741683 DOI: 10.1023/A:1022991302172 |
0.525 |
|
| 2002 |
McGary EC, Lev DC, Bar-Eli M. Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biology & Therapy. 1: 459-65. PMID 12496470 DOI: 10.4161/Cbt.1.5.158 |
0.504 |
|
| 2002 |
McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 3584-91. PMID 12429650 |
0.311 |
|
| 2002 |
Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Research. 62: 5106-14. PMID 12208768 |
0.747 |
|
| 2002 |
Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM, Bar-Eli M. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. The American Journal of Pathology. 161: 125-34. PMID 12107097 DOI: 10.1016/S0002-9440(10)64164-8 |
0.702 |
|
| 2002 |
Ghosh SK, Gadiparthi L, Zeng ZZ, Bhanoori M, Tellez C, Bar-Eli M, Rao GN. ATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cells. The Journal of Biological Chemistry. 277: 21325-31. PMID 11925444 DOI: 10.1074/Jbc.M201608200 |
0.69 |
|
| 2001 |
Nyormoi O, Wang Z, Doan D, Ruiz M, McConkey D, Bar-Eli M. Transcription Factor AP-2α Is Preferentially Cleaved by Caspase 6 and Degraded by Proteasome during Tumor Necrosis Factor Alpha-Induced Apoptosis in Breast Cancer Cells Molecular and Cellular Biology. 21: 4856-4867. PMID 11438643 DOI: 10.1128/Mcb.21.15.4856-4867.2001 |
0.301 |
|
| 2001 |
Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo. Oncogene. 20: 3363-3375. PMID 11423987 DOI: 10.1038/Sj.Onc.1204450 |
0.446 |
|
| 2001 |
Bar-Eli M. Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Research. 14: 78-85. PMID 11310795 DOI: 10.1034/J.1600-0749.2001.140202.X |
0.53 |
|
| 2001 |
Jean D, Bar-Eli M. Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: potential modality for cancer therapy. Critical Reviews in Immunology. 21: 275-286. DOI: 10.1615/Critrevimmunol.V21.I1-3.180 |
0.554 |
|
| 2000 |
Jean D, Tellez C, Huang S, Davis DW, Bruns CJ, McConkey DJ, Hinrichs SH, Bar-Eli M. Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment. Oncogene. 19: 2721-30. PMID 10851072 DOI: 10.1038/Sj.Onc.1203569 |
0.765 |
|
| 2000 |
Jean D, Bar-Eli M. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family Molecular and Cellular Biochemistry. 212: 19-28. DOI: 10.1023/A:1007128101751 |
0.53 |
|
| 1999 |
Bar-Eli M. Role of AP-2 in tumor growth and metastasis of human melanoma. Cancer and Metastasis Reviews. 18: 377-385. PMID 10721491 DOI: 10.1023/A:1006377309524 |
0.544 |
|
| 1999 |
Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin- 10: The melanoma experience Journal of Interferon and Cytokine Research. 19: 697-703. PMID 10454339 DOI: 10.1089/107999099313532 |
0.434 |
|
| 1999 |
Bar-Eli M. Role Of Interleukin-8 In Tumor Growth And Metastasis Of Human Melanoma Pathobiology. 67: 12-18. PMID 9873223 DOI: 10.1159/000028045 |
0.445 |
|
| 1998 |
Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M. CREB and its associated proteins act as survival factors for human melanoma cells. The Journal of Biological Chemistry. 273: 24884-90. PMID 9733794 DOI: 10.1074/Jbc.273.38.24884 |
0.433 |
|
| 1998 |
Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. The Journal of Biological Chemistry. 273: 16501-8. PMID 9632718 DOI: 10.1074/Jbc.273.26.16501 |
0.538 |
|
| 1998 |
Wei Q, Guan Y, Cheng L, Radinsky R, Bar-Eli M, Tsan R, Li L, Legerski RJ. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 65: 293-300. PMID 9491849 DOI: 10.1159/000164141 |
0.411 |
|
| 1997 |
Johnson JP, Bar-Eli M, Jansen B, Markhof E. Melanoma progression–associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand International Journal of Cancer. 73: 769-774. PMID 9398060 DOI: 10.1002/(Sici)1097-0215(19971127)73:5<769::Aid-Ijc26>3.0.Co;2-# |
0.454 |
|
| 1997 |
Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene. 15: 2069-75. PMID 9366524 DOI: 10.1038/Sj.Onc.1201358 |
0.536 |
|
| 1997 |
Bar-Eli M. Molecular mechanisms of melanoma metastasis Journal of Cellular Physiology. 173: 275-278. PMID 9365536 DOI: 10.1002/(Sici)1097-4652(199711)173:2<275::Aid-Jcp35>3.0.Co;2-C |
0.515 |
|
| 1997 |
Huang S, Gershenwald JE, Luca M, Gutman M, Xie S, Bar-Eli M. Molecular mechanism of melanoma metastasis Melanoma Research. 7: S59. DOI: 10.1097/00008390-199706001-00206 |
0.355 |
|
| 1997 |
Singh RK, Gershenwald JE, Gutman M, Reich R, Bar-Eli M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8: 188 Melanoma Research. 7. DOI: 10.1097/00008390-199706001-00188 |
0.345 |
|
| 1995 |
Hudson JM, Frade R, Bar-Eli M. Wild-type p53 regulates its own transcription in a cell-type specific manner. Dna and Cell Biology. 14: 759-66. PMID 7669253 DOI: 10.1089/Dna.1995.14.759 |
0.314 |
|
| 1995 |
Huang S, Xie K, Singh RK, Gutman M, Bar-Eli M. Suppression of Tumor Growth and Metastasis of Murine Renal Adenocarcinoma by Syngeneic Fibroblasts Genetically Engineered to Secrete the JE/MCP-1 Cytokine Journal of Interferon and Cytokine Research. 15: 655-665. PMID 7553238 DOI: 10.1089/Jir.1995.15.655 |
0.392 |
|
| 1994 |
Huang S, Singh RK, Xie K, Gutman M, Berry KK, Bucana CD, Fidler IJ, Bar-Eli M. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunology, Immunotherapy : Cii. 39: 231-8. PMID 7954525 DOI: 10.1007/Bf01525986 |
0.393 |
|
| 1993 |
Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Research. 3: 35-41. PMID 8471835 DOI: 10.1097/00008390-199304000-00006 |
0.456 |
|
| 1991 |
Ahuja H, Jat P, Foti A, Bar-Eli M, Cline M. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia Blood. 78: 3259-3268. DOI: 10.1182/Blood.V78.12.3259.Bloodjournal78123259 |
0.314 |
|
| 1989 |
Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 86: 6783-7. PMID 2771957 DOI: 10.1073/Pnas.86.17.6783 |
0.312 |
|
| 1989 |
Gopas J, Rager-Zisman B, Bar-Eli M, Hämmerling GJ, Segalt S. The relationship between MHC antigen expression and metastasis. Advances in Cancer Research. 53: 89-115. PMID 2678949 DOI: 10.1016/S0065-230X(08)60280-8 |
0.403 |
|
| 1989 |
Gopas J, Rager-Zisman B, Har-Vardi I, Hammerling GJ, Bar-Eli M, Segal S. NK SENSITIVITY, H-2 EXPRESSION AND METASTATIC POTENTIAL: ANALYSIS OF H-2Dk GENE TRANSFECTED FIBROSARCOMA CELLS International Journal of Immunogenetics. 16: 305-313. PMID 2639905 DOI: 10.1111/J.1744-313X.1989.Tb00476.X |
0.344 |
|
| 1988 |
Gopas J, Segal S, Hammerling G, Bar-Eli M, Rager-Zisman B. Influence of H-2K transfection on susceptibility of fibrosarcoma tumor cells to natural killer (NK) cells Immunology Letters. 17: 261-265. PMID 2836303 DOI: 10.1016/0165-2478(88)90039-9 |
0.35 |
|
| 1988 |
Bar-Eli M, Battifora H, Cline MJ. Alterations of class I HLA genes in human colon cancers. Human Genetics. 78: 86-9. PMID 2828222 DOI: 10.1007/Bf00291242 |
0.305 |
|
| 1987 |
Bar-Eli M, Hammerling GJ, Har-Vardi I, Alon Y, Segal S. Association in the expression of Ki-ras oncogene and MHC class I antigens in fibrosarcoma tumour cell variants exhibiting different metastatic capabilities European Journal of Cancer and Clinical Oncology. 23: 1732. DOI: 10.1016/0277-5379(87)90482-2 |
0.32 |
|
| 1985 |
Kris RM, Avivi A, Bar-Eli M, Alon Y, Carmi P, Schlessinger J, Raz A. Expression of ki-ras oncogene in tumor cell variants exhibiting different metastatic capabilities. International Journal of Cancer. 35: 227-30. PMID 2579034 DOI: 10.1002/Ijc.2910350214 |
0.392 |
|
| 1984 |
Lax I, Bar-Eli M, Yarden Y, Libermann TA, Schlessinger J. Antibodies to two defined regions of the transforming protein pp60src interact specifically with the epidermal growth factor receptor kinase system. Proceedings of the National Academy of Sciences of the United States of America. 81: 5911-5. PMID 6207534 DOI: 10.1073/Pnas.81.19.5911 |
0.334 |
|
| 1981 |
Koeffler HP, Bar-Eli M, Territo M. Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. The Journal of Clinical Investigation. 66: 1101-8. PMID 6253522 DOI: 10.1172/Jci109939 |
0.323 |
|
| Show low-probability matches. |